Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Myeloid Leukemia
100%
Combination Chemotherapy
100%
Adult Patients
100%
Complete Remission
33%
Cytarabine
33%
Timed Sequential Therapy
33%
Disease-free Survival
16%
Patient Selection
16%
High-risk Disease
16%
Survival Outcomes
16%
Survival Rate
16%
Induction Regimen
16%
Etoposide
16%
Improved Outcomes
16%
Recurrent Disease
16%
Patient Identification
16%
Children with Cancer
16%
Event-free Survival
16%
Durable Remission
16%
Thioguanine
16%
Idarubicin
16%
Daunorubicin
16%
Early Risk
16%
Core Binding Factor Leukemia
16%
Intensive Regimens
16%
Leukemia-free Survival
16%
Early Intensification
16%
Early Treatment Failure
16%
Intensified Regimen
16%
Nursing and Health Professions
Acute Myeloid Leukemia
100%
Combination Chemotherapy
100%
Remission
42%
Disease
28%
Cytarabine
28%
Malignant Neoplasm
14%
Survival Rate
14%
Recurrent Disease
14%
Treatment Failure
14%
Leukemia
14%
Dexamethasone
14%
Disease Free Survival
14%
Event Free Survival
14%
Etoposide
14%
Idarubicin
14%
Core Binding Factor
14%
Tioguanine
14%
Daunorubicin
14%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Chemotherapy
100%
Remission
42%
Disease
28%
Cytarabine
28%
Malignant Neoplasm
14%
Dexamethasone
14%
Recurrent Disease
14%
Disease Free Survival
14%
Survival Rate
14%
Etoposide
14%
Leukemia
14%
Daunorubicin
14%
Idarubicin
14%
Event Free Survival
14%
Core Binding Factor
14%
Tioguanine
14%